Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by consultant99on Jan 08, 2020 7:41pm
134 Views
Post# 30532703

RE:warrants

RE:warrants

I  call this a covered call strategy when using options. 

Based on today's closing prices you could buy the stock at 0.35/share and sell the warrant for a credit of (0.19)/share. This means your acquisition price for the common is now 0.16/share with an obligation to sell at $0.35/share if exercised.

The profit if called would be (0.35 -  0.16) or 0.19/share on the investment of 0.16/share. The return assuming the common is trading over 0.35 in 4.5 years from now when the warrant expires would by 118.75% (excluding commissions) for an average yield of 26.4% per year. 

the other day the warrants were trading at 0.24 and the common at 0.38 - the return based on those prices was 150% or 33.3% average yield which is pretty rich. 

I am not advocating doing this but at some price I could see others doing it to lock it some decent low risk returns.

tomchoco wrote: It would appear the someone is shorting the warrants and buying the common for a percentage trade. In options lingo, that is called a buy-write. Taking a 15-16 cent risk and will make close to 64% on his money if he gets called away.

 

Bullboard Posts